Laboratory findings at the event of INR >3.0 according to presence of WRN.

Poor Agreement among Prothrombin Time International Normalized Ratio Methods: Comparison of Seven Commercial Reagents

Juha Horsti
Juhani A Vilpo

January 2015

most popular test for monitoring oral anticoagulation therapy. The International Normalized Ratio (I...

Modified Bland-Altman plots of prothrombin time (PT), international normalized ratio (INR), and platelet counts.

Thanin Lokeskrawee (6577274)
Sombat Muengtaweepongsa (6577277)
Pattarapol Inbunleng (6577280)
Phichayut Phinyo (6577283)
Jayanton Patumanond (3424859)

April 2019

Modified Bland-Altman plots of prothrombin time (PT), international normalized ratio (INR), and plat...

248 DOI: 10.1309/AJCPGSB5YPJRREEV © American Society for Clinical Pathology Coagulation and Transfusion Medicine / Correction of INR Discrepancies Comparative Study of Blood Collection Tubes and Thromboplastin Reagents for Correction of INR Discrepancies

September 2016

International normalized ratio (INR) discrepancies were noted between clinical laboratories using va...

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies

Poller, L
Ibrahim, S
Keown, M
Pattison, A
Jespersen, J

January 2011

The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of...

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers - two independent studies

Poller, L.
Ibrahim, S.
Keown, M.
Pattison, A.
Jespersen, J.
Marun, S.
Muntean, W.
Aspoeck, Gerold
Gallus, Alex S.
Bailleul, E.
Wijns, William
Michel, T.
Jochmans, Kristin
Chatelain, B.
Marcelis, Carlo L. M.
Nijs de, A.S.
Johnston, M.
Kynde, K.
Syrjala, M.
Savolainen, E.-R.
Ivaska, K.
Rajamaki, A.
Vanharanta, R.
Juhan, I.
Aillaud, M.-F.
Guillin, M.-C.
Huisse, M.-G.
Sie, P.
Lecompte, T.
Schmitt, Y.
Harenberg, J.
Plesch, W.
Aronis, S.
Theodossiades, George
Tsoukanas, B.
Markala, D.
Ditsa, M.
Cahill, M.
Madden, M.
White, B.
Nolan, B.T.
Fitzgerald, H.
McCarthy, D.
Collins, B.
Rooney, S.
Naparstek, E.
Palareti, G.
Marongiu, F.
Erba, N.
Testa, Sophie
Mariani, G.
Poti, R.
Mannucci, P. M.
Tripodi, A.
Bader, R.
Pengo, Vittorio
Gresele, Paolo
D'inca, Marco
Ageno, W.
Tosetto, Alberto
Hensgens, H. E. S. J.
Idema, R. N.
Oosterhout, D. H.
Mulder, A. B.
Hamulyak, K.
van der Dussen, H.
Musial, J.
Gago, T.
Palmeiro, A.
Campos, Manuel
Marques-Dias, D. A.
Monteiro, A. Cunha
Cunha, M. Angela
de Gaia, W. N.
Peternel, P.
Stegnar, M.
Fontcuberta, J.
Borrell, M.
Reverter, J. C.
Santasusana, P. Domenech
Lopez-Fernandez, M. Fernanda
Castro-Montero, José Luis
Ribera Casado, C.
Vicente, Vicente
Edlund, B.
Egberg, N.
Laemmle, B.
Alberio, L.
de Moerloose, P.
Reber, G.
Machin, S. J.
Mackie, I.
Lawrie, A.
Luckit, J.
Shanks, D.
Dolan, G.
Flaherty, T.
Ludlam, C. A.
Walker, I. D.
Lawson, D. E.
Triscott, M.
Marlar, R. A.
Heit, J. A.
Watzke, H.
Weisser, B.
Osmond, J.
Cornet, I.
Munster, A.-M.
Leed, B.
Chillou, C.
Defard, M.
Horellou, M. H.
Halkin, H.
Loebstein, R.
Kirgner, I.
Dentali, F.
Trapani Lombardo, V.
Sottilotta, Gianluca
Consiglio, P.
De Michele, S.
Moia, M.
Carpenedo, Monica
Manotti, C.
Tassoni, M. Ilaria
Cosmi, B.
Brusi, C.
Legnani, C.
Pegoraro, C.
Andriani, C.
Grazia Cirigliano, M.
Ribaldi, E.
Abbate, R.
Poli, D.
Perricone, C.
Schiavuli, M.
Casiera, C.
Lupone, M. R.
Rossi, Emanuela
Crivelli, S.
Birolini, A.
Parente, F.
Miglietta, A. M.
Campobasso, M.
Sydor, W.
Krevel, B.
Fernandez, T. M. A.
Lozano, Andres M.
Shiach, C.
Bowyer, C.
Charles, F.

January 2011

The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of...

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies.

POLLER L
IBRAHIM S
KEOWN M
PATTISON A
JESPERSEN J
EUROPEAN ACTION ON A.N.T.I.C.O.A.G.U.L.A.T.I.O.N. COLLABORATORS: MARUN S
MUNTEAN W
ASPÖCK G
BAILLEUL E
WIJNS W
MICHEL T
JOCHMANS K
CHATELAIN B
MARCELIS L
NIJS AN
JOHNSTON M
KYNDE K
SYRÄJLÄ M
SAVOLAINEN ER
IVASKA K
RAJAMÄKI A
VANHARANTA R
JUHAN I
AILLAUD MF
GUILLIN MC
HUISSE MG
SIE P
LECOMPTE T
SCHMITT Y
HARENBERG J
PLESCH W
ARONIS S
THEODOSSIADES G
TSOUKANAS B
MARKALA D
DITSA M
CAHILL M
MADDEN M
FITZGERALD H
MCCARTHY D
COLLINS B
ROONEY S
NAPARSTEK E
MARONGIU F
ERBA N
TESTA S
MARIANI G
POTÌ R
MANNUCCI PM
TRIPODI A
BADER R
PENGO V
GRESELE P
D'INCÀ M
AGENO W
TOSETTO A
HENSGENS HE
IDEMA RN
OOSTERHOUT DH
MULDER AB
HAMULYAK K
VD DUSSEN H
MUSIAL J
GAGO T
PALMEIRO A
CAMPOS M
MARQUES DIAS DA
CUNHA MONTEIRO Á
ANGELA CUNHA M
DE GAIA WN
PETERNEL P
STEGNAR M
FONTCUBERTA J
BORRELL M
REVERTER JC
SANTASUSANA PD
LOPEZ FERNANDEZ MF
MONTERO J
RIBERA CASADO C
VICENTE V
EDLUND B
EGBERG N
LÄMMLE B
ALBERIO L
DE MOERLOOSE P
REBER G
MACHIN SJ
MACKIE I
LAWRIE A
LUCKIT J
SHANKS D
DOLAN G
FLAHERTY T
LUDLAM CA
WALKER ID
LAWSON DE
TRISCOTT M
MARLAR RA
HEIT JA
WATZKE H
WEISSER B
GALLUS AS
OSMOND J
CHATELAIN B
CORNET I
JOCHMANS K
MUNSTER AM
LEED B
CHILLOU C
DEFARD M
HORELLOU MH
HARENBERG J
HALKIN H
LOEBSTEIN R
NAPARSTEK E
KIRGNER I
AGENO W
DENTALI F
TRAPANI LOMBARDO V
SOTTILOTTA G
MARONGIU F
CONSIGLIO P
DE MICHELE S
MOIA M
CARPENEDO M
OLIVIERO B
BADER R
D'INCÀ M
MANOTTI C
TASSONI MI
PALARETI G
BRUSI C
LEGNANI C
PENGO V
PEGORARO C
ANDRIANI C
GRESELE P
GRAZIA CIRIGLIANO M
RIBALDI E
ABBATE R
POLI D
PERRICONE C
SCHIAVULI M
CASIERA C
LUPONE MR
ROSSI E
CRIVELLI S
BIROLINI A
POTÌ R
PARENTE F
MIGLIETTA AM
CAMPOBASSO M
MUSIAL J
SYDOR W
MARQUES DIAS DA
CAMPOS M
GAGO T
PETERNEL P
KREVEL B
STEGNAR M
FERNANDEZ MA
VICENTE V
LOZANO M
SHIACH C
BOWYER C
LUCKIT J
CHARLES F.
PALARETI, GUALTIERO
COSMI, BENILDE

January 2011

BACKGROUND: The WHO scheme for prothrombin time (PT) standardization has been limited in applicatio...

INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples

Lindahl, TL
Egberg, N
Hillarp, Andreas
Odegaard, OR
Edlund, B
Svensson, J
Sandset, PM
Ranby, M

January 2004

Prothrombin time (PT) is clinically important and is used to monitor oral anticoagulant therapy. To ...

Oral anticoagulant monitoring by laboratory or near patient testing: what a clinician should be aware of

A. Tripodi
W.G.M. Breukink-Engbers
A.M.H.P. van den Besselaar

January 2003

Prothrombin time (PT) is the primary laboratory test for monitoring oral anticoagulant treatment but...

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF <sup>*</sup>.

Kiyoshi Kubota (561420)
Nobuhiro Ooba (561411)
Yukari Kamijima (5721233)
Kuniyasu Sato (5721236)
Daisuke Koide (652787)

September 2018

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF...

STANDARDIZATION OF PROTHROMBIN TIME TEST AND EVALUATION OF QUALITY OF PATIENT MANAGEMENT WITH WARFARIN

A.H ZARGARZADEH
A.A POURAZAR
M MORABI

December 2000

Background. The most common mode of monitoring anticoagulation therapy is the use of prothrombin tim...

How to report results of prothrombin time and activated partial thromboplastin time

A. Tripodi
G. Lippi
M. Plebani

February 2016

Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the most widely used test...

Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy

Johanna H. H. Van Geest-daalderop
Andre ́ B. Mulder
Ra J. M. Boonman-de Winter
Martha M. C. L. Hoekstra

December 2014

Background: The quality of oral anticoagulant therapy management with coumarin derivatives requires ...

How to report results of prothrombin and activated partial thromboplastin times

Tripodi, Armando
Plebani, Mario
LIPPI, Giuseppe

January 2016

Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the most widely used test...

Effect of Time and Temperature Variables on Prothrombin Time and International Normalized Ratio of Plasma in Patients in Gampaha, Sri Lanka

Ranasınghe, Vıraj
Jayasundara, Sameera Maduranga
Sılva, Sanjaya De
Marikar, Faiz
Yapa, Randıka Wımalasırı

December 2022

Generating accurate results for Prothrombin time (PT) and International Normalized Ratio (INR), PT/I...

Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins

Besselaar, A.M.H.P. van den
Cobbaert, C.M.

November 2021

Introduction The definition of the International Normalized Ratio (INR) depends on a reference measu...

Poor Agreement among Prothrombin Time International Normalized Ratio Methods: Comparison of Seven Commercial Reagents

Juha Horsti
Juhani A Vilpo

January 2015

most popular test for monitoring oral anticoagulation therapy. The International Normalized Ratio (I...

Modified Bland-Altman plots of prothrombin time (PT), international normalized ratio (INR), and platelet counts.

Thanin Lokeskrawee (6577274)
Sombat Muengtaweepongsa (6577277)
Pattarapol Inbunleng (6577280)
Phichayut Phinyo (6577283)
Jayanton Patumanond (3424859)

April 2019

Modified Bland-Altman plots of prothrombin time (PT), international normalized ratio (INR), and plat...

248 DOI: 10.1309/AJCPGSB5YPJRREEV © American Society for Clinical Pathology Coagulation and Transfusion Medicine / Correction of INR Discrepancies Comparative Study of Blood Collection Tubes and Thromboplastin Reagents for Correction of INR Discrepancies

September 2016

International normalized ratio (INR) discrepancies were noted between clinical laboratories using va...

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies

Poller, L
Ibrahim, S
Keown, M
Pattison, A
Jespersen, J

January 2011

The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of...

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers - two independent studies

Poller, L.
Ibrahim, S.
Keown, M.
Pattison, A.
Jespersen, J.
Marun, S.
Muntean, W.
Aspoeck, Gerold
Gallus, Alex S.
Bailleul, E.
Wijns, William
Michel, T.
Jochmans, Kristin
Chatelain, B.
Marcelis, Carlo L. M.
Nijs de, A.S.
Johnston, M.
Kynde, K.
Syrjala, M.
Savolainen, E.-R.
Ivaska, K.
Rajamaki, A.
Vanharanta, R.
Juhan, I.
Aillaud, M.-F.
Guillin, M.-C.
Huisse, M.-G.
Sie, P.
Lecompte, T.
Schmitt, Y.
Harenberg, J.
Plesch, W.
Aronis, S.
Theodossiades, George
Tsoukanas, B.
Markala, D.
Ditsa, M.
Cahill, M.
Madden, M.
White, B.
Nolan, B.T.
Fitzgerald, H.
McCarthy, D.
Collins, B.
Rooney, S.
Naparstek, E.
Palareti, G.
Marongiu, F.
Erba, N.
Testa, Sophie
Mariani, G.
Poti, R.
Mannucci, P. M.
Tripodi, A.
Bader, R.
Pengo, Vittorio
Gresele, Paolo
D'inca, Marco
Ageno, W.
Tosetto, Alberto
Hensgens, H. E. S. J.
Idema, R. N.
Oosterhout, D. H.
Mulder, A. B.
Hamulyak, K.
van der Dussen, H.
Musial, J.
Gago, T.
Palmeiro, A.
Campos, Manuel
Marques-Dias, D. A.
Monteiro, A. Cunha
Cunha, M. Angela
de Gaia, W. N.
Peternel, P.
Stegnar, M.
Fontcuberta, J.
Borrell, M.
Reverter, J. C.
Santasusana, P. Domenech
Lopez-Fernandez, M. Fernanda
Castro-Montero, José Luis
Ribera Casado, C.
Vicente, Vicente
Edlund, B.
Egberg, N.
Laemmle, B.
Alberio, L.
de Moerloose, P.
Reber, G.
Machin, S. J.
Mackie, I.
Lawrie, A.
Luckit, J.
Shanks, D.
Dolan, G.
Flaherty, T.
Ludlam, C. A.
Walker, I. D.
Lawson, D. E.
Triscott, M.
Marlar, R. A.
Heit, J. A.
Watzke, H.
Weisser, B.
Osmond, J.
Cornet, I.
Munster, A.-M.
Leed, B.
Chillou, C.
Defard, M.
Horellou, M. H.
Halkin, H.
Loebstein, R.
Kirgner, I.
Dentali, F.
Trapani Lombardo, V.
Sottilotta, Gianluca
Consiglio, P.
De Michele, S.
Moia, M.
Carpenedo, Monica
Manotti, C.
Tassoni, M. Ilaria
Cosmi, B.
Brusi, C.
Legnani, C.
Pegoraro, C.
Andriani, C.
Grazia Cirigliano, M.
Ribaldi, E.
Abbate, R.
Poli, D.
Perricone, C.
Schiavuli, M.
Casiera, C.
Lupone, M. R.
Rossi, Emanuela
Crivelli, S.
Birolini, A.
Parente, F.
Miglietta, A. M.
Campobasso, M.
Sydor, W.
Krevel, B.
Fernandez, T. M. A.
Lozano, Andres M.
Shiach, C.
Bowyer, C.
Charles, F.

January 2011

The WHO scheme for prothrombin time (PT) standardization has been limited in application, because of...

The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies.

POLLER L
IBRAHIM S
KEOWN M
PATTISON A
JESPERSEN J
EUROPEAN ACTION ON A.N.T.I.C.O.A.G.U.L.A.T.I.O.N. COLLABORATORS: MARUN S
MUNTEAN W
ASPÖCK G
BAILLEUL E
WIJNS W
MICHEL T
JOCHMANS K
CHATELAIN B
MARCELIS L
NIJS AN
JOHNSTON M
KYNDE K
SYRÄJLÄ M
SAVOLAINEN ER
IVASKA K
RAJAMÄKI A
VANHARANTA R
JUHAN I
AILLAUD MF
GUILLIN MC
HUISSE MG
SIE P
LECOMPTE T
SCHMITT Y
HARENBERG J
PLESCH W
ARONIS S
THEODOSSIADES G
TSOUKANAS B
MARKALA D
DITSA M
CAHILL M
MADDEN M
FITZGERALD H
MCCARTHY D
COLLINS B
ROONEY S
NAPARSTEK E
MARONGIU F
ERBA N
TESTA S
MARIANI G
POTÌ R
MANNUCCI PM
TRIPODI A
BADER R
PENGO V
GRESELE P
D'INCÀ M
AGENO W
TOSETTO A
HENSGENS HE
IDEMA RN
OOSTERHOUT DH
MULDER AB
HAMULYAK K
VD DUSSEN H
MUSIAL J
GAGO T
PALMEIRO A
CAMPOS M
MARQUES DIAS DA
CUNHA MONTEIRO Á
ANGELA CUNHA M
DE GAIA WN
PETERNEL P
STEGNAR M
FONTCUBERTA J
BORRELL M
REVERTER JC
SANTASUSANA PD
LOPEZ FERNANDEZ MF
MONTERO J
RIBERA CASADO C
VICENTE V
EDLUND B
EGBERG N
LÄMMLE B
ALBERIO L
DE MOERLOOSE P
REBER G
MACHIN SJ
MACKIE I
LAWRIE A
LUCKIT J
SHANKS D
DOLAN G
FLAHERTY T
LUDLAM CA
WALKER ID
LAWSON DE
TRISCOTT M
MARLAR RA
HEIT JA
WATZKE H
WEISSER B
GALLUS AS
OSMOND J
CHATELAIN B
CORNET I
JOCHMANS K
MUNSTER AM
LEED B
CHILLOU C
DEFARD M
HORELLOU MH
HARENBERG J
HALKIN H
LOEBSTEIN R
NAPARSTEK E
KIRGNER I
AGENO W
DENTALI F
TRAPANI LOMBARDO V
SOTTILOTTA G
MARONGIU F
CONSIGLIO P
DE MICHELE S
MOIA M
CARPENEDO M
OLIVIERO B
BADER R
D'INCÀ M
MANOTTI C
TASSONI MI
PALARETI G
BRUSI C
LEGNANI C
PENGO V
PEGORARO C
ANDRIANI C
GRESELE P
GRAZIA CIRIGLIANO M
RIBALDI E
ABBATE R
POLI D
PERRICONE C
SCHIAVULI M
CASIERA C
LUPONE MR
ROSSI E
CRIVELLI S
BIROLINI A
POTÌ R
PARENTE F
MIGLIETTA AM
CAMPOBASSO M
MUSIAL J
SYDOR W
MARQUES DIAS DA
CAMPOS M
GAGO T
PETERNEL P
KREVEL B
STEGNAR M
FERNANDEZ MA
VICENTE V
LOZANO M
SHIACH C
BOWYER C
LUCKIT J
CHARLES F.
PALARETI, GUALTIERO
COSMI, BENILDE

January 2011

BACKGROUND: The WHO scheme for prothrombin time (PT) standardization has been limited in applicatio...

INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples

Lindahl, TL
Egberg, N
Hillarp, Andreas
Odegaard, OR
Edlund, B
Svensson, J
Sandset, PM
Ranby, M

January 2004

Prothrombin time (PT) is clinically important and is used to monitor oral anticoagulant therapy. To ...

Oral anticoagulant monitoring by laboratory or near patient testing: what a clinician should be aware of

A. Tripodi
W.G.M. Breukink-Engbers
A.M.H.P. van den Besselaar

January 2003

Prothrombin time (PT) is the primary laboratory test for monitoring oral anticoagulant treatment but...

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF <sup>*</sup>.

Kiyoshi Kubota (561420)
Nobuhiro Ooba (561411)
Yukari Kamijima (5721233)
Kuniyasu Sato (5721236)
Daisuke Koide (652787)

September 2018

The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF...

STANDARDIZATION OF PROTHROMBIN TIME TEST AND EVALUATION OF QUALITY OF PATIENT MANAGEMENT WITH WARFARIN

A.H ZARGARZADEH
A.A POURAZAR
M MORABI

December 2000

Background. The most common mode of monitoring anticoagulation therapy is the use of prothrombin tim...

How to report results of prothrombin time and activated partial thromboplastin time

A. Tripodi
G. Lippi
M. Plebani

February 2016

Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the most widely used test...

Preanalytical Variables and Off-Site Blood Collection: Influences on the Results of the Prothrombin Time/International Normalized Ratio Test and Implications for Monitoring of Oral Anticoagulant Therapy

Johanna H. H. Van Geest-daalderop
Andre ́ B. Mulder
Ra J. M. Boonman-de Winter
Martha M. C. L. Hoekstra

December 2014

Background: The quality of oral anticoagulant therapy management with coumarin derivatives requires ...

How to report results of prothrombin and activated partial thromboplastin times

Tripodi, Armando
Plebani, Mario
LIPPI, Giuseppe

January 2016

Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the most widely used test...

Effect of Time and Temperature Variables on Prothrombin Time and International Normalized Ratio of Plasma in Patients in Gampaha, Sri Lanka

Ranasınghe, Vıraj
Jayasundara, Sameera Maduranga
Sılva, Sanjaya De
Marikar, Faiz
Yapa, Randıka Wımalasırı

December 2022

Generating accurate results for Prothrombin time (PT) and International Normalized Ratio (INR), PT/I...

Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins

Besselaar, A.M.H.P. van den
Cobbaert, C.M.

November 2021

Introduction The definition of the International Normalized Ratio (INR) depends on a reference measu...

Poor Agreement among Prothrombin Time International Normalized Ratio Methods: Comparison of Seven Commercial Reagents

Juha Horsti
Juhani A Vilpo

January 2015

most popular test for monitoring oral anticoagulation therapy. The International Normalized Ratio (I...

Modified Bland-Altman plots of prothrombin time (PT), international normalized ratio (INR), and platelet counts.

Thanin Lokeskrawee (6577274)
Sombat Muengtaweepongsa (6577277)
Pattarapol Inbunleng (6577280)
Phichayut Phinyo (6577283)
Jayanton Patumanond (3424859)

April 2019

Modified Bland-Altman plots of prothrombin time (PT), international normalized ratio (INR), and plat...

248 DOI: 10.1309/AJCPGSB5YPJRREEV © American Society for Clinical Pathology Coagulation and Transfusion Medicine / Correction of INR Discrepancies Comparative Study of Blood Collection Tubes and Thromboplastin Reagents for Correction of INR Discrepancies

September 2016

International normalized ratio (INR) discrepancies were noted between clinical laboratories using va...

Laboratory findings at the event of INR >3.0 according to presence of WRN.

Abstract

Extracted data

Laboratory findings at the event of INR >3.0 according to presence of WRN.

Abstract

Extracted data

Related items

Related items